ArrayExpress Uploader04915parthenolideparthenolideparthenolideparthenolideparthenolideparthenolideparthenolideparthenolideparthenolideparthenolideparthenolideparthenolidecontrolcontrolcontrolcontrolcontrolcontrolcontrolcontrolcontrolcontrolcontrolcontrolarrayexpress_sid4The effects of 7.5 micromolar parthenolide (PTL) were assessed on primary CD34+ acute myelogenous leukemia specimens obtained from 12...18305216E-GEOD-7538/profile/8773/arrayexpressuploader124leftleukemiaDec.12, 2014Falsetranscription-profiling-of-human-primary-cd34-acutE-GEOD-7538_A-AFFY-44Transcription profiling of human primary CD34+ acute myelogenous leukemia specimens obtained from 12 patients treated with 7.5 micromolar parthenolide (PTL)Sep.22, 2014The effects of 7.5 micromolar parthenolide (PTL) were assessed on primary CD34+ acute myelogenous leukemia specimens obtained from 12 patients. Experiment Overall Design: Acute myelogenous leukemia (AML) specimens were obtained from 12 patients and CD34+ cells were isolated. For each patient, cells were cultured in vitro and exposed to either 7.5 micromolar parthenolide (PTL) or left untreated (UT) for 6 h. Total RNA was then harvested for global gene expression analysis.http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-7538humanhttp://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-7538/samples/